Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lithium cation
Drug ID BADD_D01304
Description Lithium was used during the 19th century to treat gout. Lithium salts such as lithium carbonate (Li2CO3), lithium citrate, and lithium orotate are mood stabilizers. They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they counteract both mania and depression. Lithium can also be used to augment other antidepressant drugs. It is also sometimes prescribed as a preventive treatment for migraine disease and cluster headaches. The active principle in these salts is the lithium ion Li+, which having a smaller diameter, can easily displace K+ and Na+ and even Ca+2, in spite of its greater charge, occupying their sites in several critical neuronal enzymes and neurotransmitter receptors.
Indications and Usage Lithium, in its salt forms, is used as a mood stabilizer and for the treatment of depression and mania. It is most frequently prescribed in the treatment of bipolar disorder.
Marketing Status experimental
ATC Code N05AN01
DrugBank ID DB01356
KEGG ID D08133
MeSH ID D008094
PubChem ID 28486
TTD Drug ID D5MF8Y
NDC Product Code Not Available
UNII 8H8Z5UER66
Synonyms Lithium | Lithium-7 | Lithium 7
Chemical Information
Molecular Formula Li+
CAS Registry Number 17341-24-1
SMILES [Li+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Respiratory depression17.02.05.047; 22.02.01.0100.000192%-
Respiratory failure14.01.04.003; 22.02.06.0020.001536%
Restlessness17.02.05.021; 19.11.02.0020.000480%
Rhabdomyolysis15.05.05.0020.000384%
Salivary gland enlargement07.06.03.002---
Salivary hypersecretion07.06.01.0090.000518%-
Schizoaffective disorder19.03.02.0020.000384%-
Sedation17.02.04.0050.002304%-
Seizure17.12.03.001--
Serotonin syndrome12.03.01.041; 15.05.04.016; 17.05.02.0040.001440%-
Sexual dysfunction19.08.05.002; 21.03.02.003---
Shock24.06.02.002---
Sinus arrhythmia02.03.03.008---
Sinus bradycardia02.03.03.0090.000288%
Skin ulcer23.07.03.003; 24.04.03.007--
Sluggishness08.01.01.0040.000192%-
Somnolence17.02.04.006; 19.02.05.0030.002285%
Speech disorder17.02.08.003; 19.19.02.002; 22.12.03.0270.000576%-
Staring19.01.01.0030.000192%-
Status epilepticus17.12.03.0050.000576%-
Stress19.06.02.0040.000422%-
Stupor17.02.04.007; 19.02.05.0040.000288%-
Suicidal ideation19.12.01.0030.000864%
Suicide attempt19.12.01.0040.002496%
Swelling08.01.03.015---
Syncope02.11.04.015; 17.02.04.008; 24.06.02.0120.000576%
Tachycardia02.03.02.0070.001383%-
Tachypnoea22.02.01.0140.000288%-
Tardive dyskinesia17.01.02.0120.000192%-
Therapeutic response decreased08.06.01.0160.000518%-
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 11 Pages